New cell therapy offers hope for kids with rare leukemia
Disease control
Recruiting now
This study tests a treatment called CART19, which uses a patient's own immune cells modified to attack leukemia cells. It is for children and young adults with certain high-risk types of B-cell acute lymphoblastic leukemia (B-ALL) that are hard to treat. The goal is to see if thi…
Phase: PHASE2 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC